Evidence map›Paper›PMID 26311050›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma.

Dexiang Zhang, Yuedi Dai, Yuankun Cai, Tao Suo, Han Liu, Yueqi Wang, Zhijian Cheng, Houbao Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Characterization of PEBP-like Genes and Function ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Dexiang ZhangGeneral Surgery Department, The Fifth People's Hospital of Shanghai, Fudan University, 128 Ruili Rd., Shanghai, 200240, China.
Yuedi DaiDepartment of Medical Oncology, Cancer Hospital of Fudan University, Minhang Branch, Shanghai, 200240, China.
Yuankun CaiGeneral Surgery Department, The Fifth People's Hospital of Shanghai, Fudan University, 128 Ruili Rd., Shanghai, 200240, China.
Tao SuoGeneral Surgery Department, General Surgery Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Han LiuGeneral Surgery Department, General Surgery Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Yueqi WangGeneral Surgery Department, General Surgery Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Zhijian ChengGeneral Surgery Department, The Fifth People's Hospital of Shanghai, Fudan University, 128 Ruili Rd., Shanghai, 200240, China. chengzhijian2015@tom.com.
Houbao LiuGeneral Surgery Department, General Surgery Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China. liuhoubao66@sina.com.
Fudan University · CNZhongshan Hospital · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most common malignancies in the world. Numerous studies have linked the activation of AKT to the progression of PDAC. Phosphatidylethanolamine-binding protein 4 (PEBP4) has been reported to be upregulated in various cancer types. However, its expression pattern and biological functions in PDAC are unknown. In this study, it was found that the messenger RNA (mRNA) and protein level of PEBP4 was elevated in PDAC samples. Forced expression of PEBP4 in PDAC cell lines promoted cell growth and migration, while downregulation of PEBP4 in PDAC cells by RNA interference (RNAi) inhibited the growth, migration, and metastasis of the cancer cells. PEBP4 interacted with AKT and promoted the phosphorylation of serine 473 in AKT. Collectively, this study suggested that PEBP4 might promote the progression of PDAC through activating AKT signaling and PEBP4 might be a promising therapeutic target for PDAC treatment.

Indexed as

Cell MovementAnimalsBlotting, WesternCarcinoma, Pancreatic DuctalCell ProliferationHeterograftsHumansImmunohistochemistryImmunoprecipitationMicePancreatic NeoplasmsPhosphatidylethanolamine Binding ProteinReal-Time Polymerase Chain ReactionTransfectionPE-binding protein 4, humanPhosphatidylethanolamine Binding ProteinAKTCell growth and migrationPDACPEBP4

Identifiers

PMID26311050
OpenAlexW1739050906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.